BioNTech SE
NASDAQ:BNTX
BioNTech SE
NASDAQ:BNTX
Price:
97.88 USD
-2.45%
Updated:
Jun 10, 2024
Net Margin
BioNTech SE
BioNTech SE
4.1%
Current
46%
Average
-8.5%
Industry
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin
=4.1%
Net Income
/
113m
Revenue
2.7B
Net Margin Across Competitors
| Country | DE |
| Market Cap | 23.3B USD |
| Net Margin |
4%
|
| Country | US |
| Market Cap | 297.2B USD |
| Net Margin |
11%
|
| Country | US |
| Market Cap | 162.3B USD |
| Net Margin |
13%
|
| Country | US |
| Market Cap | 124.1B USD |
| Net Margin |
39%
|
| Country | US |
| Market Cap | 109.6B USD |
| Net Margin |
29%
|
| Country | AU |
| Market Cap | 139.6B AUD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 80.2B USD |
| Net Margin |
2%
|
| Country | US |
| Market Cap | 56.3B USD |
| Net Margin |
-116%
|
| Country | US |
| Market Cap | 43.1B USD |
| Net Margin |
-33%
|
| Country | US |
| Market Cap | 33B USD |
| Net Margin |
12%
|
| Country | KR |
| Market Cap | 39.3T KRW |
| Net Margin |
17%
|
Profitability Report
View the profitability report to see the full profitability analysis for BioNTech SE.
See Also
Discover More
What is Net Margin?
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin
=4.1%
Net Income
/
113m
Revenue
2.7B
What is the Net Margin of BioNTech SE?
Based on BioNTech SE's most recent financial statements, the company has Net Margin of 4.1%.
You don't have any saved screeners yet
